There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - House of Representatives

Short Titles as Introduced

Medicare Negotiation and Competitive Licensing Act of 2019

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate prices of prescription drugs furnished under part D of the Medicare program.


Actions Overview (1)

Date
02/07/2019Introduced in House

All Actions (6)

Date
09/25/2019Subcommittee Hearings Held.
Action By: House Energy and Commerce Subcommittee on Health
02/08/2019Referred to the Subcommittee on Health.
Action By: Committee on Energy and Commerce
02/07/2019Referred to the Subcommittee on Health.
Action By: Committee on Ways and Means
02/07/2019Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Action By: House of Representatives
02/07/2019Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Action By: House of Representatives
02/07/2019Introduced in House
Action By: House of Representatives

Cosponsors (127)

* = Original cosponsor
CosponsorDate Cosponsored
Rep. Welch, Peter [D-VT-At Large]* 02/07/2019
Rep. Cummings, Elijah E. [D-MD-7]* 02/07/2019
Rep. Adams, Alma S. [D-NC-12]* 02/07/2019
Rep. Bass, Karen [D-CA-37]* 02/07/2019
Rep. Beatty, Joyce [D-OH-3]* 02/07/2019
Rep. Blumenauer, Earl [D-OR-3]* 02/07/2019
Rep. Bonamici, Suzanne [D-OR-1]* 02/07/2019
Rep. Cartwright, Matt [D-PA-8]* 02/07/2019
Rep. Case, Ed [D-HI-1]* 02/07/2019
Rep. Casten, Sean [D-IL-6]* 02/07/2019
Rep. Castor, Kathy [D-FL-14]* 02/07/2019
Rep. Castro, Joaquin [D-TX-20]* 02/07/2019
Rep. Chu, Judy [D-CA-27]* 02/07/2019
Rep. Cicilline, David N. [D-RI-1]* 02/07/2019
Rep. Cisneros, Gilbert Ray, Jr. [D-CA-39]* 02/07/2019
Rep. Clay, Wm. Lacy [D-MO-1]* 02/07/2019
Rep. Cleaver, Emanuel [D-MO-5]* 02/07/2019
Rep. Cohen, Steve [D-TN-9]* 02/07/2019
Rep. Courtney, Joe [D-CT-2]* 02/07/2019
Rep. Crist, Charlie [D-FL-13]* 02/07/2019
Rep. Crow, Jason [D-CO-6]* 02/07/2019
Rep. Davis, Danny K. [D-IL-7]* 02/07/2019
Rep. DeFazio, Peter A. [D-OR-4]* 02/07/2019
Rep. DeLauro, Rosa L. [D-CT-3]* 02/07/2019
Rep. DeSaulnier, Mark [D-CA-11]* 02/07/2019
Rep. Dingell, Debbie [D-MI-12]* 02/07/2019
Rep. Doyle, Michael F. [D-PA-18]* 02/07/2019
Rep. Escobar, Veronica [D-TX-16]* 02/07/2019
Rep. Espaillat, Adriano [D-NY-13]* 02/07/2019
Rep. Evans, Dwight [D-PA-3]* 02/07/2019
Rep. Frankel, Lois [D-FL-21]* 02/07/2019
Rep. Gallego, Ruben [D-AZ-7]* 02/07/2019
Rep. Garamendi, John [D-CA-3]* 02/07/2019
Rep. Golden, Jared F. [D-ME-2]* 02/07/2019
Rep. Gonzalez, Vicente [D-TX-15]* 02/07/2019
Rep. Green, Al [D-TX-9]* 02/07/2019
Rep. Grijalva, Raul M. [D-AZ-3]* 02/07/2019
Rep. Haaland, Debra A. [D-NM-1]* 02/07/2019
Rep. Harder, Josh [D-CA-10]* 02/07/2019
Rep. Hastings, Alcee L. [D-FL-20]* 02/07/2019
Rep. Higgins, Brian [D-NY-26]* 02/07/2019
Rep. Hill, Katie [D-CA-25]* 02/07/2019
Rep. Jackson Lee, Sheila [D-TX-18]* 02/07/2019
Rep. Jayapal, Pramila [D-WA-7]* 02/07/2019
Rep. Johnson, Eddie Bernice [D-TX-30]* 02/07/2019
Rep. Kaptur, Marcy [D-OH-9]* 02/07/2019
Rep. Khanna, Ro [D-CA-17]* 02/07/2019
Rep. Kim, Andy [D-NJ-3]* 02/07/2019
Rep. Kirkpatrick, Ann [D-AZ-2]* 02/07/2019
Rep. Krishnamoorthi, Raja [D-IL-8]* 02/07/2019
Rep. Langevin, James R. [D-RI-2]* 02/07/2019
Rep. Larson, John B. [D-CT-1]* 02/07/2019
Rep. Lawson, Al, Jr. [D-FL-5]* 02/07/2019
Rep. Lee, Barbara [D-CA-13]* 02/07/2019
Rep. Lee, Susie [D-NV-3]* 02/07/2019
Rep. Levin, Andy [D-MI-9]* 02/07/2019
Rep. Lewis, John [D-GA-5]* 02/07/2019
Rep. Lipinski, Daniel [D-IL-3]* 02/07/2019
Rep. Loebsack, David [D-IA-2]* 02/07/2019
Rep. Lofgren, Zoe [D-CA-19]* 02/07/2019
Rep. Lowenthal, Alan S. [D-CA-47]* 02/07/2019
Rep. Lynch, Stephen F. [D-MA-8]* 02/07/2019
Rep. Maloney, Carolyn B. [D-NY-12]* 02/07/2019
Rep. Maloney, Sean Patrick [D-NY-18]* 02/07/2019
Rep. McCollum, Betty [D-MN-4]* 02/07/2019
Rep. McNerney, Jerry [D-CA-9]* 02/07/2019
Rep. Moore, Gwen [D-WI-4]* 02/07/2019
Rep. Nadler, Jerrold [D-NY-10]* 02/07/2019
Rep. Napolitano, Grace F. [D-CA-32]* 02/07/2019
Rep. Neguse, Joe [D-CO-2]* 02/07/2019
Rep. Norton, Eleanor Holmes [D-DC-At Large]* 02/07/2019
Rep. Ocasio-Cortez, Alexandria [D-NY-14]* 02/07/2019
Rep. Omar, Ilhan [D-MN-5]* 02/07/2019
Rep. Perlmutter, Ed [D-CO-7]* 02/07/2019
Rep. Peterson, Collin C. [D-MN-7]* 02/07/2019
Rep. Phillips, Dean [D-MN-3]* 02/07/2019
Rep. Pingree, Chellie [D-ME-1]* 02/07/2019
Rep. Pocan, Mark [D-WI-2]* 02/07/2019
Rep. Porter, Katie [D-CA-45]* 02/07/2019
Rep. Pressley, Ayanna [D-MA-7]* 02/07/2019
Rep. Raskin, Jamie [D-MD-8]* 02/07/2019
Rep. Richmond, Cedric L. [D-LA-2]* 02/07/2019
Rep. Rose, Max [D-NY-11]* 02/07/2019
Rep. Roybal-Allard, Lucille [D-CA-40]* 02/07/2019
Rep. Ruppersberger, C. A. Dutch [D-MD-2]* 02/07/2019
Rep. Rush, Bobby L. [D-IL-1]* 02/07/2019
Rep. Ryan, Tim [D-OH-13]* 02/07/2019
Rep. Sarbanes, John P. [D-MD-3]* 02/07/2019
Rep. Schakowsky, Janice D. [D-IL-9]* 02/07/2019
Rep. Schiff, Adam B. [D-CA-28]* 02/07/2019
Rep. Scott, Robert C. "Bobby" [D-VA-3]* 02/07/2019
Rep. Serrano, Jose E. [D-NY-15]* 02/07/2019
Rep. Sherman, Brad [D-CA-30]* 02/07/2019
Rep. Slotkin, Elissa [D-MI-8]* 02/07/2019
Rep. Spanberger, Abigail Davis [D-VA-7]* 02/07/2019
Rep. Suozzi, Thomas R. [D-NY-3]* 02/07/2019
Rep. Takano, Mark [D-CA-41]* 02/07/2019
Rep. Thompson, Bennie G. [D-MS-2]* 02/07/2019
Rep. Titus, Dina [D-NV-1]* 02/07/2019
Rep. Tlaib, Rashida [D-MI-13]* 02/07/2019
Rep. Torres, Norma J. [D-CA-35]* 02/07/2019
Rep. Velazquez, Nydia M. [D-NY-7]* 02/07/2019
Rep. Visclosky, Peter J. [D-IN-1]* 02/07/2019
Rep. Wasserman Schultz, Debbie [D-FL-23]* 02/07/2019
Rep. Waters, Maxine [D-CA-43]* 02/07/2019
Rep. Wild, Susan [D-PA-7]* 02/07/2019
Rep. Yarmuth, John A. [D-KY-3]* 02/07/2019
Rep. Malinowski, Tom [D-NJ-7]* 02/07/2019
Rep. Garcia, Jesus G. [D-IL-4] 02/11/2019
Rep. Morelle, Joseph D. [D-NY-25] 02/11/2019
Rep. Soto, Darren [D-FL-9] 02/14/2019
Rep. Delgado, Antonio [D-NY-19] 02/14/2019
Rep. Huffman, Jared [D-CA-2] 02/25/2019
Rep. Clarke, Yvette D. [D-NY-9] 02/25/2019
Rep. Gabbard, Tulsi [D-HI-2] 02/25/2019
Rep. Lieu, Ted [D-CA-33] 02/25/2019
Rep. Wilson, Frederica S. [D-FL-24] 02/27/2019
Rep. Scanlon, Mary Gay [D-PA-5] 03/05/2019
Rep. Mucarsel-Powell, Debbie [D-FL-26] 03/07/2019
Rep. Price, David E. [D-NC-4] 03/08/2019
Rep. Fudge, Marcia L. [D-OH-11] 03/25/2019
Rep. Beyer, Donald S., Jr. [D-VA-8] 03/27/2019
Rep. Luria, Elaine G. [D-VA-2] 05/07/2019
Rep. Carson, Andre [D-IN-7] 05/22/2019
Rep. Pappas, Chris [D-NH-1] 05/23/2019
Rep. Lawrence, Brenda L. [D-MI-14] 06/19/2019
Rep. Jeffries, Hakeem S. [D-NY-8] 09/10/2019

Committees (2)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
House Energy and Commerce02/07/2019 Referred to
House Energy and Commerce Subcommittee on Health02/08/2019 Referred to
09/25/2019 Hearings by
House Ways and Means02/07/2019 Referred to
House Ways and Means Subcommittee on Health02/07/2019 Referred to

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.


Latest Summary (1)

There is one summary for H.R.1046. View summaries

Shown Here:
Introduced in House (02/07/2019)

Medicare Negotiation and Competitive Licensing Act of 2019

This bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. (Current law prohibits the CMS from doing so.)

The CMS must take certain factors into account during negotiations, including the clinical- and cost-effectiveness of the drug, the financial burden on patients, and unmet patient needs. If the CMS is unable to negotiate the price of a drug, such drug is subject to competitive licensing in order to further its sale under Medicare, notwithstanding existing government-granted exclusivities.

Additionally, for one year after a drug is provided under a competitive license, such drug is also subject to specified price limitations; if the drug is not offered at such prices, the drug is subject to additional licensing that furthers its sale under any federal program (e.g., Medicaid).